UPB-101

DRUG2 trials

Sponsors

Upstream Bio Inc.

Conditions

AsthmaHealthy

Phase 1

Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics

CompletedNCT05448651

Upstream Bio Inc.Asthma

Start: 2022-07-08End: 2023-10-05Updated: 2025-01-03

Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults

CompletedNCT05653479

Upstream Bio Inc.Healthy

Start: 2022-12-05End: 2023-05-13Updated: 2024-09-03